SOFTBANK TECH CORP 

$19.43
3
+$0+0% Wednesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
442.18M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 25
$1,988,351.07
Jun 25
$2,614,914.26
Jun 24
$2,614,914.26
Dec 23
$1,988,351.07
Jun 23
$2,601,331.82
10Y Growth
5.71%
5Y Growth
2.78%
3Y Growth
0.1%
1Y Growth
N/A

Earnings

29OctExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2024
Q2 2024
Q3 2024
0.11
23.82
47.54
71.25
Expected EPS
N/A
Actual EPS
N/A

Financials

12.57%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
448.28MRevenue
56.36MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SFBTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences is a biopharmaceutical company that competes in the development of treatments similar to VG Life Sciences, focusing on areas such as infectious diseases.
AMGEN
AMGN
Mkt Cap178B
Amgen is a biotech firm that competes with VG Life Sciences in the development of innovative therapies and drugs, particularly in the areas of oncology and cardiovascular diseases.
Merck
MRK
Mkt Cap277.02B
Merck & Co. is a global healthcare company that develops pharmaceuticals across various areas, including those that overlap with VG Life Sciences' research interests.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a pharmaceutical corporation with a broad range of products in various therapeutic areas, competing with VG Life Sciences in the development and marketing of drugs.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb is a biopharmaceutical company that develops drugs in areas like cancer, competing directly with VG Life Sciences in the oncology sector.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie operates in the pharmaceutical industry, focusing on treatments for conditions in areas such as immunology and oncology, making it a competitor to VG Life Sciences.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that produces drugs in several therapeutic areas, including those that compete with VG Life Sciences' research and development focus.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with VG Life Sciences in the biotechnology and pharmaceutical sectors.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson is a diversified healthcare company that develops and sells pharmaceuticals and biopharmaceuticals, competing with VG Life Sciences across multiple therapeutic areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals is a biotechnology company that develops and commercializes medicines for serious medical conditions, directly competing with VG Life Sciences in the biopharmaceutical field.

About

Internet Software/Services
Technology Services
SB Technology Corp. provides ICT services in Japan. The company offers data analysis and visualization services; security solutions; IT infrastructure solutions; and cloud solutions, as well as creates functional e-commerce sites to operating sites. It is also involved in planning, design, development, and operation of IT systems, mobile apps, and IoT apps. The company was formerly known as SoftBank Technology Corp. and changed its name to SB Technology Corp. in October 2019. The company was founded in 1990 and is headquartered in Tokyo, Japan.
Show more...
CEO
Shinichi Ata
Employees
1447
Country
Japan

Listings

0 Comments

Share your thoughts

FAQ

What is SOFTBANK TECH CORP stock price today?
The current price of SFBTF is $19.43 USD — it has increased by +0% in the past 24 hours. Watch SOFTBANK TECH CORP stock price performance more closely on the chart.
What is SOFTBANK TECH CORP stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange SOFTBANK TECH CORP stocks are traded under the ticker SFBTF.
What is SOFTBANK TECH CORP market cap?
Today SOFTBANK TECH CORP has the market capitalization of 442.18M
What is SOFTBANK TECH CORP revenue for the last year?
SOFTBANK TECH CORP revenue for the last year amounts to 448.28M USD.
What is SOFTBANK TECH CORP net income for the last year?
SFBTF net income for the last year is 56.36M USD.
Does SOFTBANK TECH CORP pay dividends?
Yes, SFBTF dividends are paid semi-annual. The last dividend per share was 1,988,351.07 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does SOFTBANK TECH CORP have?
As of May 06, 2026, the company has 1,447 employees.
In which sector is SOFTBANK TECH CORP located?
SOFTBANK TECH CORP operates in the Other sector.
When did SOFTBANK TECH CORP complete a stock split?
The last stock split for SOFTBANK TECH CORP was on September 06, 2024 with a ratio of 1:9900000.
Where is SOFTBANK TECH CORP headquartered?
SOFTBANK TECH CORP is headquartered in Shinjuku Ku, Japan.